Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03)

被引：0
|
作者：
Jens Jakob
Anna Simeonova
Bernd Kasper
Ulrich Ronellenfitsch
Geraldine Rauch
Frederik Wenz
Peter Hohenberger
机构：
[1] University Medical Center and Medical Faculty Mannheim,Division of Surgical, Oncology and Thoracic Surgery, Department of Surgery
[2] University of Heidelberg,Department of Radiation Oncology
[3] University Medical Center Mannheim,Sarcoma Unit, Interdisciplinary Tumor Center Mannheim
[4] University of Heidelberg,Division of Surgical, Oncology and Thoracic Surgery, Department of Surgery
[5] Mannheim University Medical Center,Institute of Medical Biometry and Informatics
[6] University of Heidelberg,Department of Radiation Oncology
[7] University Medical Center Mannheim,undefined
[8] University of Heidelberg,undefined
[9] University of Heidelberg,undefined
[10] University Medical Center and Medical Faculty Mannheim,undefined
[11] University of Heidelberg,undefined
来源：
Radiation Oncology | / 11卷
关键词：
Sunitinib; Soft Tissue Sarcoma; Dose Limit Toxicity; Intensity Modulate Radiation Therapy; Clinical Target Volume;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Margin reduction from image guided radiation therapy for soft tissue sarcoma: Secondary analysis of Radiation Therapy Oncology Group 0630 results
    Li, X. Allen
    Chen, Xiaojian
    Zhang, Qiang
    Kirsch, David G.
    Petersen, Ivy
    DeLaney, Thomas F.
    Freeman, Carolyn R.
    Trotti, Andy
    Hitchcock, Ying
    Bedi, Meena
    Haddock, Michael
    Salerno, Kilian
    Dundas, George
    Wang, Dian
    PRACTICAL RADIATION ONCOLOGY, 2016, 6 (04) : E135 - E140
  • [42] Preoperative Dose-Escalated Intensity-Modulated Radiotherapy (IMRT) and Intraoperative Radiation Therapy (IORT) in Patients with Retroperitoneal Soft-Tissue Sarcoma: Final Results of a Clinical Phase I/II Trial
    Seidensaal, Katharina
    Dostal, Matthias
    Kudak, Andreas
    Jaekel, Cornelia
    Meixner, Eva
    Liermann, Jakob
    Weykamp, Fabian
    Hoegen, Philipp
    Mechtersheimer, Gunhild
    Willis, Franziska
    Schneider, Martin
    Debus, Juergen
    CANCERS, 2023, 15 (10)
  • [43] Prospective phase I/II trial to investigate preoperative IMRT, surgery and IOERT in retroperitoneal soft tissue sarcoma: interim analysis
    Roeder, F.
    Ulrich, A.
    Habl, G.
    Uhl, M.
    Saleh-Ebrahimi, L.
    Huber, P. E.
    Schulz-Ertner, D.
    Nikoghosyan, A.
    Alldinger, I
    Krempien, R.
    Mechtersheimer, G.
    Hensley, F. W.
    Debus, J.
    Bischof, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 11 - 12
  • [44] Prospective Phase I/II Trial to Investigate Preoperative IMRT, Surgery and IOERT in Retroperitoneal Soft Tissue Sarcoma: Interim Analysis
    Roeder, F.
    Ulrich, A.
    Habl, G.
    Uhl, M.
    Saleh-Ebrahimi, L.
    Huber, P. E.
    Schulz-Ertner, D.
    Nikoghosyan, A.
    Alldinger, I.
    Krempien, R.
    Mechtersheimer, G.
    Hensley, F. W.
    Debus, J.
    Bischof, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S117 - S117
  • [45] Phase I/II study to evaluate penpulimab combined with anlotinib and epirubicin in the first-line treatment of soft tissue sarcoma: Phase I dose escalation results
    Zhou, Y.
    Feng, Y.
    Li, W.
    Zhuang, R.
    You, Y.
    Zhang, C.
    Wang, Z.
    Liu, W.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1232 - S1232
  • [46] Histology and outcome in localized high-risk soft tissue sarcomas (STS) treated with preoperative chemotherapy (CHT) with or without radiation therapy (RT) within a phase III trial from the Italian Sarcoma Group (ISG) and the Spanish Sarcoma Group (GEIS).
    Casali, P. G.
    Stacchiotti, S.
    Verderio, P.
    Collini, P.
    Tos, A. P. Dei
    Alberghini, M.
    Llombart-Bosch, A.
    Morosi, C.
    Messina, A.
    Mercuri, M.
    Gronchi, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [47] Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13)
    Kasper, Bernd
    Pink, Daniel
    Rothermundt, Christian
    Richter, Stephan
    Augustin, Marinela
    Kollar, Attila
    Kunitz, Annegret
    Eisterer, Wolfgang
    Gaidzik, Verena
    Brodowicz, Thomas
    Egerer, Gerlinde
    Reichardt, Peter
    Hohenberger, Peter
    Schuler, Markus K.
    CANCERS, 2024, 16 (03)
  • [48] Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic 18F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group
    Sachpekidis, Christos
    Karampinis, Ioannis
    Jakob, Jens
    Kasper, Bernd
    Nowak, Kai
    Pilz, Lothar
    Attenberger, Ulrike
    Gaiser, Timo
    Derigs, Hans-Guenter
    Schwarzbach, Matthias
    Hohenberger, Peter
    Dimitrakopoulou-Strauss, Antonia
    Ronellenfitsch, Ulrich
    CANCERS, 2019, 11 (06)
  • [49] Neoadjuvant Pazopanib Treatment In High-risk Soft Tissue Sarcoma: A Quantitative Dynamic 18F-FDG PET/CT Study Of The German Interdisciplinary Sarcoma Group
    Sachpekidis, C.
    Karampinis, I.
    Jakob, J.
    Kasper, B.
    Nowak, K.
    Pilz, L.
    Attenberger, U.
    Gaiser, T.
    Derigs, H. G.
    Schwarzbach, M.
    Hohenberger, P.
    Dimitrakopoulou-Strauss, A.
    Ronellenfitsch, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S302 - S303
  • [50] Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma:: a study by the EORTC Soft Tissue and Bone Sarcoma Group
    Judson, I
    Radford, JA
    Harris, M
    Blay, JY
    van Hoesel, Q
    le Cesne, A
    van Oosterom, AT
    Clemons, MJ
    Kamby, C
    Hermans, C
    Whittaker, J
    di Paola, ED
    Verweij, J
    Nielsen, S
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (07) : 870 - 877
12345